Genome sequence analysis of nsp15 from SARS-CoV-2.

Bioinformation

Department of Chemistry, V.K.S. University, Ara-802301, Bihar India.

Published: April 2022

SARS-CoV-2 (Severe Acute Respiratory Syndrome), a causative agent of COVID-19 disease created a pandemic situation worldwide. Nsp15 is a uridine specific endoribonuclease encoded by the genome of SARS-CoV-2. It plays important role in processing viral RNA and, thus evades the host immune system. Therefore, it is of interest to identify mutants of nsp15 amongst Asian SARS-CoV-2 isolates, where a total of 1795 mutations, from 7793 sequences of Asia submitted till 31st January 2022, amongst which A231V, H234Y, K109N, K259R and S261A mutations were found frequent. Hence, we report data on the predicted secondary structure of wild type form followed by hydropathy plot, physiochemical properties, Ramachandran plot, B-cell epitopes prediction and protein modeling of wild type and mutant of nsp15 protein. Data shows that nsp15 of SARS-CoV-2 is a pontential candidate for the development of vaccine to control the infections of SARS-CoV-2.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997503PMC
http://dx.doi.org/10.6026/97320630018432DOI Listing

Publication Analysis

Top Keywords

nsp15 sars-cov-2
8
wild type
8
sars-cov-2
6
nsp15
5
genome sequence
4
sequence analysis
4
analysis nsp15
4
sars-cov-2 sars-cov-2
4
sars-cov-2 severe
4
severe acute
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!